Inhibitory role of oxytocin in psychostimulant-induced psychological dependence and its effects on dopaminergic and glutaminergic transmission

Acta Pharmacologica Sinica

Volumn 31, Issue 9, 2010, Pages 1071-1074

  Yang, Jing Yu ^a   Qi, Jia ^a,b   Han, Wen Yan ^a   Wang, Fang ^a   Wu, Chun Fu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

cocaine; dopamine; glutamate; methamphetamine; oxytocin; psychostimulants

Indexed keywords

COCAINE; DIAMORPHINE; GLUTAMIC ACID; METHAMPHETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; OXYTOCIN; OXYTOCIN RECEPTOR; PSYCHOSTIMULANT AGENT;

AMYGDALOID NUCLEUS; BEHAVIOR CHANGE; CENTRAL NERVOUS SYSTEM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; FOREBRAIN; GLUTAMINERGIC TRANSMISSION; HUMAN; LIMBIC SYSTEM; MESOLIMBIC DOPAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; PREFRONTAL CORTEX; REVIEW; STRIA TERMINALIS;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; GLUTAMIC ACID; HUMANS; OXYTOCIN; SUBSTANCE-RELATED DISORDERS;

EID: 77956377419     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.140     Document Type: Review

References (47)

1. Dackis CA, Gold MS. "Addictiveness of central stimulants". Adv Alcohol Subst Abuse 1990; 9: 9-26.
2. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987; 94:469-492.
3. Koob GF. Neural mechanisms of drug reinforcement. Ann NY Acad Sci 1992; 654: 171-191.
4. Wise RA. Dopamine, learning and motivation. Nat Rev Neurosci 2004; 5: 483-494
5. Koob GF, Caine SB, Parsons L, Markou A, Weiss F. Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav 1997; 57: 513-521
6. Taber MT, Das S, Fibiger HC. Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem 1995; 65: 1407-1410.
7. Zavala AR, Weber SM, Rice HJ, Alleweireldt AT, Neisewander JL. Role of the prelimbic subregion of the medial prefrontal cortex in acquisition, extinction, and reinstatement of cocaine-conditioned place preference. Brain Res 2003; 990: 157-164
8. Hao Y, Yang JY, Wu CF, Wu MF. Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice. Pharmacol Biochem Behav 2007; 86: 660-666.
9. De LM, Oliveira SB, Reisser A, Farrell M. Pharmacological treatment of cocaine dependence: A systematic review. Addiction 2002; 97: 931-949
10. Kreek M, Laforge K, Butelman E. Pharmacotherapy of addictions. Nature 2002; 1: 710-726
11. Shearer J, Gowing L. Pharmacotherapies for problematic psychostimulant use: A review of current research. Drug Alcohol Depen 2004; 23: 203-211
12. Sarnyai Z, Kovacs GL. Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrino 1994; 19: 85-117.
13. Kovacs GL, Van Ree JM. Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. Life Sci 1985; 37: 1895-1900
14. Krivan M, Szabo G, Sarnyai Z, Kovacs GL, Telegdy G. Oxytocin blocks the development of heroin-enkephalin crosstolerance in mice. Pharmacol Biochem Behav 1992; 43: 187-192
15. Krivan M, Szabo G, Sarnyai Z, Kovacs GL, Telegdy G. Oxytocin blocks the development of heroin-fentanyl crosstolerance in mice. Pharmacol Biochem Behav 1995; 52: 591-594
16. Sarnyai Z. Oxytocin and neuroadaptation to cocaine. Prog Brain Res 1998; 119: 449-466
17. Qi J, Yang JY, Song M, Li Y, Wang F, Wu CF. Inhibition by oxytocin of methamphetamine -induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn-Schmiedebergs Arch Pharmacol 2008; 376: 441-448
18. Qi J, Yang JY, Wang F, Zhao YN, Song M, Wu CF. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 2009; 56: 856-865
19. Sarnyai Z, Babarczy E, Krivan M, Szabo G, Kovacs GL, et al. Selective attenuation of cocaine-induced stereotyped behaviour by oxytocin: putative role of basal forebrain target sites. Neuropeptides 1991; 19: 51-56
20. Sarnyai Z, Biro E, Babarczy E, Vecsernyes M, Laczi F, et al. Oxytocin modulates behavioural adaptation to repeated treatment with cocaine in rats. Neuropharmacology 1992; 31: 593-598
21. Kovacs GL, Sarnyai Z, Barbarczi E, Szabo G, Telegdy G. The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity. Neuropharmacology 1990; 29: 365-368
22. Angelica RC, Anderlise B, Gabriela AM, Pereira AB. Lucion effects of oxytocin microinjected into the central amygdaloid nucleus and bed nucleus of stria terminalis on maternal aggressive behavior in rats. Physiol Behav 2005; 85: 354-362
23. Stewart J, Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 1993; 4: 289-312.
24. Hyman SE. Addiction to cocaine and amphetamine. Neuron1996; 16: 901-904
25. Zoltán S, Gyula S, Gábor LK, Gyula T. Opposite actions of oxytocin and vasopressin in the development of cocaine-induced behavioral sensitization in mice. Pharmacol Biochem Behav 1992; 43: 491-494
26. Carson DS, Cornish JL, Guastella AJ, Hunt GE, McGregor JS. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology 2010; 58: 38-43.
27. Bardo MT, Bevins RA. Conditioned place preference: what does it add to our preclinicalunderstandingof drug reward? Psychopharmacology 2000; 153: 31-43.
28. Parker LA, McDonald RV. Reinstatement of both a conditioned place preference and a conditioned place aversion with drug primes. Pharmacol Biochem Behav 2000; 66: 559-561
29. Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 2006; 30: 215-238
30. Brigner C, Nordenankar K, Martin L, Mendez JA, Smith C. VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation. Proc Natl Acad Sci USA 2010; 107:389-394
31. Liu Y, Wang ZX. Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles. Neuroscience 2003; 121: 537-544
32. Kovacs GL, Sarnyai Z, Szabo G. Oxytocin and addiction: a review. Psychoneuroendocrino 1998; 23: 945-962
33. Sarnyai Z, Babarczy E, Kriván M, Szabó M, Kovács GL, et al. Selective attenuation of cocaine-induced stereotyped behaviour by oxytocin: Putative role of basal forebrain target sites. Neuropeptides 1991; 19: 51-56
34. Goeders NE, Dworkin SI, Smith JE. Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex. Pharmacol Biochem Behav 1986; 24: 1429-1440
35. Hao Y, Yang JY, Guo M, Wu CF, Wu MF. Morphine decreases extracellular levels of glutamate in the anterior cingulate cortex: an in vivo microdialysis study in freely moving rats. Brain Res 2005; 1040: 191-196
36. Amano T, Matsubayashi H, Sasa M. Hypersensitivity of nucleus accumbens neurons to methamphetamine and dopamine following repeated administrations of methamphetamine. Ann NY Acad Sci 1996; 801: 136-147
37. Broom SL, Yamamoto BK. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats. Psychopharmacology 2005; 181: 467-476
38. Izawa J, Yamanashi K, Asakura T, Misu Y and Goshima Y. Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats. Eur J Pharmacol 2006; 549: 84-90.
39. Pulvirenti L. Glutamate neurotransmission in the course of cocaine addiction. In: Herman BH. Glutamate and Addiction. Humana Press 2003; 171-181
40. Condes-Lara M, Maie IA, Dickenson AH. Oxytocin actions on afferent evoked spinal cord neuronal activities in neuropathic but not in normal rats. Brain Res 2005; 1045: 124-133
41. Condes-Lara M, Rojas-Piloni G, Martinez-Lorenzana G, Rodriguez-Jimenez J, Lopez-Hidalgo M, et al. Paraventricular hypothalamic influences on spinal nociceptive processing. Brain Res 2006; 1081: 126-137
42. Jo YH, Stoeckel ME, Freund-Mercier MJ, Schlichter R. Oxytocin modulates glutamatergic synaptic transmission between cultured neonatal spinal corddorsal horn neurons. J Neurosci 1998; 18: 2377-2386
43. Robinson DA, Wei F, Wang GD, Li P, Kim SJ, et al. Oxytocin mediates stress-induced analgesia in adult mice. J Physiol 2002; 540: 593-606.
44. Tatsushi O, Kinji Y. Facilitative modulation by NMDA receptors of vasopressin and oxytocin responses to osmotic stimuli in rats. Neurosci Res 1998; 31: 240.
45. Liu CY, Xie DP, Liu KJ, Zhou YQ, Liu JZ. Oxytocin microinjected into dorsal motor nucleus of the vagus excites gallbladder motility via NMDA receptor-NO-cGMP pathway. Brain Res 2005; 1032: 116-122
46. Qi J, Wang LH, Yang JY, Wu CF. Effects of oxytocin on changes of N-methyl-D-aspartate receptor 1 expression in prefrontal cortex and hippocampus of mice induced by methamphetamine. J Shenyang Pharm Univ 2008; 25: 825-830 Chinese.
47. Zoltán S, Gábor LK. Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrinology 1994; 19: 85-117.